One new retrospective study showed that GLP-1 RAs were associated with a reduced risk of colorectal cancer with and without obesity, suggesting potential protective effects mediated by weight loss and other effects not related to weight loss [79]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.